Revised Out of Specification (OOS) Guidance | USFDA Guidance | OOS Guidance May 2022
25:27
21 CFR Part 11 | Electronic Records & Electronic Signatures | GxP Computer System requirements
44:52
Nitrosamine Impurities-Aug 2023 NDSRIs Limit USFDA Guidance | Control of Nitrosamine Guidance Feb-21
24:36
Out Of Specification (OOS) Investigation Phase Ia & Phase Ib (MHRA)
1:29:02
How to Handle OOS Investigations
11:54
MHRA || OOS Guideline ||
1:48:11
Out of Specification & Out of Trend Investigations
30:34
Mastering Out of Specification (OOS) in the Pharmaceutical Industry: A Step-by-Step Guide
29:59